Clearance Summary
VENTRI-CATH received FDA 510(k) clearance under submission number K931989, sponsored by Gesco Intl., Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 1993-07-21.
- Submission: K931989
- Applicant / Sponsor: Gesco Intl., Inc.
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.5550
- Decision date: 1993-07-21
Classification & Regulation
This clearance is catalogued under FDA product code JXG and 21 CFR 882.5550, within the Neurology review panel as a Class II device.